Skip to content
Recall Observatory FDA recall evidence

Drug product

Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.

D-1217-2015

June 30, 2015

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc
Event
Event 71566
Status
Terminated
Classification
Class II
Quantity
1068 bottles
Official record key
drug-enforcement:D-1217-2015

Official wording

Reason: Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Code information: Lot #: 3053562, Exp 02/16

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification